Menu
Back to Journals » Clinical Interventions in Aging » Volume 8
Optimal treatment of actinic keratoses
Authors Uhlenhake E
Received 30 October 2012
Accepted for publication 4 December 2012
Published 14 January 2013 Volume 2013:8 Pages 29—35
DOI https://doi.org/10.2147/CIA.S31930
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Elizabeth E Uhlenhake
Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, USA
Abstract: The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin.
Keywords: actinic keratosis, photodynamic therapy, topical chemotherapy, field therapy
A Letter to the Editor has been received and published for this article.
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.